Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Barnidipine hydrochloride

SKU: orb1301427

Description

Barnidipine hydrochloride

Research Area

Metabolism Research, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number104757-53-1
MW528
Purity99.88% (May vary between batches)
FormulaC27H30ClN3O6
SMILESCl.COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@H]1CCN(Cc2ccccc2)C1
TargetCalcium Channel
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.47 mM);DMSO:250 mg/mL (473.48 mM)

Bioactivity

Target IC50
[3H]-Initrendipine:0.21 nmol/l (Ki)
In Vivo
Barnidipine demonstrates antihypertensive activity by reducing peripheral vascular resistance. It decreases blood pressure in spontaneously hypertensive rats when administered orally at 1 and 3 mg/kg per day. Formulations containing barnidipine have been used as a treatment for hypertension. In obstructive sleep apnea patients with non-dipper pattern hypertension, barnidipine reduced mean nighttime systolic and diastolic arterial blood pressure.
Animal Research
Forty-one patients (mean age 69 ± 17 years, 18 females) with previously diagnosed OSA (by reduced channel home-based polysomnography) who were not being treated with continuous positive airway pressure (CPAP) because of contraindications or because of patient intolerance or rejection were evaluated. Non-dipper status was defined as the presence of a nighttime fall in systolic blood pressure (BP) which was < 10% that of daytime systolic BP as observed in a previous ambulatory blood pressure (ABP) monitoring. OSA was defined according to the presence of 5 or more episodes per hour of apnoea, hypopnoea or arousal due to respiratory effort. The reproducibility of non-dipping status was confirmed through a second 24-h ABP monitoring performed at baseline. On top of the previous stable treatment regimen (which excluded calcium-channel blockers), a 10 mg dosing of barnidipine hydrochloride at bedtime was added to all subjects during a 12-week period.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

inhibit, Inhibitor, Mepirodipine, Mepirodipine (hydrochloride), Calcium Channel, Ca channels, Ca2+ channels, Barnidipine, Barnidipine hydrochloride, Barnidipine Hydrochloride, CalciumChannel, YM-09730-5 hydrochloride, YM-09730-5 Hydrochloride

Similar Products

  • Barnidipine [orb1220661]

    >98% (HPLC)

    104757-53-1

    528

    C27H30ClN3O6

    10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
  • (S)-1-Benzylpyrrolidin-3-ol [orb2901879]

    >98% (HPLC)

    101385-90-4

    177.247

    C11H15NO

    100 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 ml x 10 mM (in DMSO)
$ 70.00
50 mg
$ 70.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry